As the world eagerly awaits the end of the pandemic through massive vaccination efforts, many scientists are still working hard on finding non-vaccine solutions for COVID-19. Merck and Pfizer respectively developed the antivirals, Molnupiravir and Paxlovid — both of which show potential in curbing the seriousness of SARS-CoV2 infections. Now, there’s another breakthrough: an experimental gum for COVID-19 appears to reduce the viral load by up to 95%, potentially reducing not just the spread but also the severe symptoms.
Comments
Share your thoughts
Be the first to let Hello Doctor know your thoughts!
Join Us or Log In to join the discussion